SEC Form 4 · accession 0001179110-16-026867
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven C Gilman
Director
Period of report
Jun 22, 2016
Accepted (ET)
Jun 24, 2016 · 3:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $10.63 | Jun 22, 2016 | A | 33,000 | A | — | Jun 22, 2026 | Common Stock | 33,000 | 33,000 | D |
Explanation of responses
- F1Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan.
- F2The stock option will vest and become exercisable with respect to 11,000 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent two years, all vesting is subject to Dr. Gilman's continued service to the Company through the applicable vesting date.